|
|||||
|
|
A short review of ciraparantag in perspective of the currently available anticoagulant reversal agents |
|
| Affiliation: | 1. Department of Internal Medicine & Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands;2. Heinrich-Heine-University Duesseldorf, Medical Faculty, Department of Cardiology, Pulmonology and Vascular Medicine, Duesseldorf, Germany |
| Abstract: | |
| Keywords: | Ciraparantag Anticoagulants Antidote Idarucizumab Andexanet |
| 本文献已被 ScienceDirect 等数据库收录！ | |